Iqirvo
1 known investors
IQIRVO is a prescription medicine for treating primary biliary cholangitis (PBC) in adults, used either in combination with ursodeoxycholic acid or as a standalone treatment for patients unable to tolerate standard therapy.
Investors · 1
Frequently asked questions
- What does Iqirvo do?
- IQIRVO is a prescription medicine for treating primary biliary cholangitis (PBC) in adults, used either in combination with ursodeoxycholic acid or as a standalone treatment for patients unable to tolerate standard therapy.
- Who are Iqirvo's investors?
- Iqirvo's investors include HEALTHCARE ROYALTY PARTNERS.